Raymond L Benza Selected Research

sitaxsentan

12/2015	Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension.
10/2008	Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survival.
1/2007	Sitaxsentan treatment for patients with pulmonary arterial hypertension discontinuing bosentan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raymond L Benza Research Topics

Disease

51	Pulmonary Arterial Hypertension 01/2022 - 12/2005
24	Pulmonary Hypertension 11/2021 - 12/2005
13	Heart Failure 11/2020 - 09/2002
6	Connective Tissue Diseases (Connective Tissue Disease) 01/2020 - 03/2006
5	Disease Progression 11/2021 - 02/2013
5	Hypertension (High Blood Pressure) 01/2021 - 07/2008
4	Headache (Headaches) 01/2021 - 12/2011
4	Heart Diseases (Heart Disease) 01/2021 - 01/2002
3	Neoplasms (Cancer) 11/2021 - 12/2005
3	Cough 01/2021 - 12/2011
3	Hypotension (Low Blood Pressure) 01/2021 - 02/2015
3	Cardiac Arrhythmias (Arrythmia) 11/2020 - 05/2009
3	Sepsis (Septicemia) 11/2019 - 05/2002
3	Infections 10/2019 - 05/2002
3	Cardiomyopathies (Cardiomyopathy) 10/2019 - 03/2003
3	Thrombosis (Thrombus) 10/2019 - 05/2014
3	Hypoxia (Hypoxemia) 01/2018 - 01/2016
3	Vascular Diseases (Vascular Disease) 01/2017 - 05/2003
3	Congenital Heart Defects (Congenital Heart Defect) 01/2007 - 03/2006
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 05/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 11/2021 - 01/2021
2	Vascular Remodeling 10/2021 - 05/2007
2	Lung Diseases (Lung Disease) 01/2021 - 01/2019
2	Renal Insufficiency (Renal Failure) 01/2021 - 07/2010
2	COVID-19 11/2020 - 10/2020
2	Pericardial Effusion 03/2015 - 07/2010
2	Fibrosis (Cirrhosis) 07/2014 - 11/2012
2	Nausea 02/2013 - 12/2011
2	Liver Diseases (Liver Disease) 05/2009 - 07/2008
2	Coronary Artery Disease (Coronary Atherosclerosis) 05/2007 - 01/2002
1	Thrombophilia 11/2021
1	Familial Primary Pulmonary Hypertension 01/2021
1	Dyspepsia (Indigestion) 01/2021
1	Hemorrhage 01/2021
1	Right Ventricular Hypertrophy 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 01/2021
1	Obesity 01/2021
1	Osteoarthritis 01/2021
1	Pregnancy Complications 01/2021
1	Nervous System Diseases (Neurological Disorders) 11/2020
1	Stroke (Strokes) 01/2020
1	Morbid Obesity 11/2019

Drug/Important Bio-Agent (IBA)

12	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2022 - 12/2005
12	treprostinil FDA Link 01/2022 - 12/2005
11	riociguatIBA 10/2021 - 02/2015
8	Bosentan (Tracleer)FDA Link 10/2020 - 04/2006
6	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2021 - 03/2013
5	Pharmaceutical PreparationsIBA 10/2021 - 01/2002
5	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 07/2010
4	Endothelins (Endothelin)IBA 07/2014 - 07/2008
3	selexipagIBA 12/2021 - 01/2019
3	Oxygen (Dioxygen)IBA 11/2021 - 01/2018
3	macitentanIBA 01/2021 - 07/2014
3	Phosphodiesterase 5 InhibitorsIBA 10/2020 - 03/2013
3	Sildenafil Citrate (Viagra)FDA Link 10/2020 - 07/2008
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 09/2011
3	Biological ProductsIBA 01/2017 - 07/2008
3	sitaxsentanIBA 12/2015 - 01/2007
3	Endothelin Receptor AntagonistsIBA 11/2012 - 04/2006
2	ProstaglandinsIBA 01/2022 - 12/2011
2	Iloprost (Ventavis)FDA Link 12/2021 - 02/2013
2	DiureticsIBA 11/2021 - 04/2004
2	7-(N-(3-aminopropyl)amino)heptan-2-oneIBA 01/2021 - 01/2021
2	ElectrolytesIBA 11/2020 - 04/2004
2	Vasodilator Agents (Vasodilators)IBA 10/2020 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 08/2011
2	Milrinone (Primacor)FDA LinkGeneric 08/2004 - 03/2003
1	Blood Group Antigens (Blood Groups)IBA 11/2021
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2021
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 10/2021
1	Phosphotransferases (Kinase)IBA 10/2021
1	Macrophage Colony-Stimulating FactorIBA 10/2021
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	Epoprostenol ReceptorsIBA 01/2021
1	pro-brain natriuretic peptide (1-76)IBA 01/2021
1	Oral ContraceptivesIBA 01/2021
1	ambrisentan FDA Link 01/2021
1	Tadalafil (Cialis)FDA Link 01/2021
1	Illicit Drugs (Recreational Drugs)IBA 01/2021
1	AnticoagulantsIBA 01/2021
1	cyclo(Arg-Pro) (CI 4)IBA 01/2020
1	Hormones (Hormone)IBA 04/2019
1	CytokinesIBA 07/2018
1	Aldehyde DehydrogenaseIBA 01/2018
1	SmokeIBA 01/2018

Therapy/Procedure

38	Therapeutics 01/2022 - 01/2002
11	Heart-Assist Devices 11/2020 - 05/2002
5	Lung Transplantation 01/2019 - 09/2012
4	Heart Transplantation (Grafting, Heart) 05/2007 - 01/2002
3	Transplantation 01/2019 - 01/2004
2	Precision Medicine 12/2021 - 01/2017
2	Liver Transplantation 11/2012 - 05/2009
1	Thoracotomy 01/2021
1	Continuity of Patient Care 11/2020
1	Critical Care (Surgical Intensive Care) 01/2019
1	Extracorporeal Membrane Oxygenation 01/2019
1	Treatment Delay 01/2018